Want to join the conversation?
$XOM 2Q15 Q&A: On a question asked by Good of Morningstar regarding cost savings internationally, Jeff answered that XOM is capturing cost savings across its global portfolio. On the cost side, ongoing structural improvements and additional market savings in the down cycle. Well positioned to capture the book on the cost and the capital side.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?